Vestibular migraine is a leading yet often overlooked cause of recurring vertigo and dizziness. This guide explains the key symptoms, how it differs from other balance disorders, and the treatment options available in the UK to help manage episodes effectively.
Vestibular migraine is now considered the most common cause of spontaneous episodic vertigo, yet it remains one of the most frequently missed diagnoses in both neurology and ENT practice. People can live with recurring episodes of vertigo, dizziness and disorientation for years, cycling through investigations and referrals, without anyone connecting their symptoms to migraine.
Part of the problem is that vestibular migraine does not always behave the way people expect migraine to behave. Headache may be mild, absent altogether, or follow the vestibular episode rather than accompany it. The vertigo itself can last anywhere from five minutes to 72 hours, varies considerably between attacks and presents differently in different people. That variability makes it a condition that genuinely rewards specialist assessment rather than pattern-matching against a textbook description.
What Is Vestibular Migraine?
Vestibular migraine is a neurological condition in which migraine pathophysiology produces recurring vestibular symptoms, most commonly vertigo, dizziness, imbalance and motion sensitivity. The vestibular symptoms are causally linked to the migraine process, not simply coincidental to it.
Formal diagnostic criteria were first established in 2012 by a joint committee of the Bárány Society and the International Headache Society, and updated by consensus in 2021. Vestibular migraine appears in the appendix of the third edition of the International Classification of Headache Disorders as a recognised episodic syndrome associated with migraine. Its formal inclusion in international classification reflects how far the understanding of this condition has moved over the past two decades.
The condition was previously described under several different names, including migrainous vertigo, migraine-associated vertigo and migraine-related vestibulopathy. These terms referred to the same underlying clinical picture. Vestibular migraine is now the accepted term across specialist practice.
How It Differs From Other Causes of Vertigo
Vestibular migraine can be exceptionally difficult to separate from other vestibular conditions, particularly Ménière’s disease and BPPV. All three can produce episodic vertigo. The key distinctions lie in the duration of attacks, the associated features and the pattern over time.
Unlike BPPV, vestibular migraine does not reliably trigger with specific head positions and episodes last far longer than seconds or minutes. Unlike Ménière’s disease, hearing is typically normal, and tinnitus or aural fullness, whilst possible, are not consistent features. Unlike vestibular neuritis, episodes are recurrent rather than a single prolonged event. These distinctions matter, but in practice, they are not always clean, which is one reason vestibular migraine is so often delayed in diagnosis.
How Common Is Vestibular Migraine?
Vestibular migraine is more prevalent than most clinicians realise. The lifetime prevalence is approximately 1%, and the one-year prevalence is around 0.9% in the general population. A large US population-based survey found a prevalence of 2.7% of adults amongst those reporting dizziness or balance problems, suggesting that the condition is considerably underdiagnosed when people with active symptoms are specifically examined.
Among people who already have a diagnosis of migraine, the rates are substantially higher. The prevalence amongst migraine patients has been reported at 10.3% in a large multicentre study. That means vestibular migraine is not a rare outlier; it is a recognised and common phenotype within the broader migraine population.
Women are affected more often than men. The same population survey found a female preponderance of 64.1%, with a mean age of around 40 years in those affected. A 2024 narrative review from King’s College London described a bimodal pattern of presentation in women, likely reflecting the influence of hormonal factors across different life stages, particularly around perimenopause.
What Causes Vestibular Migraine?
The exact mechanism by which migraine produces vestibular symptoms is not yet fully understood, but research points to a complex interaction between the trigeminovascular system and the vestibular pathways in the brain.
One leading hypothesis involves the release of calcitonin gene-related peptide (CGRP) and other pro-inflammatory neuropeptides during a migraine attack. CGRP has connections with both the areas that process pain and those associated with vestibular and spatial orientation processing. Research has shown that CGRP plays a role in the trigeminal and vestibular nucleus pathways, which provides a plausible biological bridge between headache and vestibular symptoms. This link is also relevant to treatment, as CGRP-targeting therapies developed for migraine are now being explored in vestibular migraine.
Other proposed mechanisms include inner ear hypoperfusion during attacks, cortical spreading depression affecting vestibular cortical areas and sensitisation of the central vestibular system. Neuroimaging studies have found abnormal activity and connectivity in multiple brain regions in vestibular migraine, supporting the idea that this is a condition of altered sensory processing rather than structural inner ear damage.
Triggers and Risk Factors
Vestibular migraine shares many of the same triggers as migraine more broadly. Common ones include hormonal fluctuations, sleep disruption, stress, dehydration, dietary factors and certain foods. People with vestibular migraine also tend to have a longstanding history of motion sickness, which is now recognised as a clinically useful pointer. One study of 131 vestibular migraine patients found that 61% reported motion sickness, a rate substantially higher than in other vestibular conditions. Asking about childhood and adult motion sensitivity is, therefore, a worthwhile part of the clinical history.
A family history of migraine is common, and there is evidence of genetic susceptibility. The condition has a strong association with anxiety and depression, though whether these are causes, consequences or co-expressions of the same underlying neurology remains an area of active research.
Recognising the Symptoms of Vestibular Migraine
The symptoms of vestibular migraine are episodic and variable. No two people present in exactly the same way, and the same person may experience different episode patterns over time. This variability is one of the defining characteristics of the condition and one of the reasons it is so often overlooked.
Episodes can involve one or more of the following vestibular symptoms:
- Spontaneous vertigo, where the world spins without any positional trigger
- Positional vertigo, brought on by head movements or changes in body position
- Visually induced vertigo, triggered by moving images, busy environments or scrolling screens
- Head motion-induced dizziness, where turning the head produces disorientation or nausea
- Unsteadiness and imbalance without obvious spinning
What Happens During and Between Attacks
Episodes last between five minutes and 72 hours, though most last less than an hour. During an attack, some people experience a headache, whilst others have no headache at all or develop it only after the vestibular symptoms have settled. Associated features during attacks may include photosensitivity, phonosensitivity, visual aura, nausea and heightened sensitivity to head movement.
Between attacks, some people feel completely normal. Others notice persistent mild unsteadiness, motion sensitivity or difficulty in visually complex environments that does not fully resolve between episodes. This interictal picture, where symptoms linger between the main attacks, can create overlap with PPPD and represents one of the diagnostic challenges in this area.
It is also worth noting that in most people with vestibular migraine, the migraine history predates the vestibular symptoms by some years. One study found that migraine occurred earlier than vestibular symptoms in 67.7% of patients. This temporal pattern, where vertigo arrives years after headache is already established, is a useful diagnostic clue.
How Vestibular Migraine Is Diagnosed
Vestibular migraine is a clinical diagnosis. There is no blood test, audiogram or imaging finding that confirms it, and standard vestibular function tests are often normal between attacks. Diagnosis depends on taking a careful and comprehensive history that maps the episodes, associated features and migraine background against a structured set of criteria.
The Bárány Society and IHS Diagnostic Criteria
The 2021 consensus criteria require all of the following to be met for a diagnosis of definite vestibular migraine:
- At least five episodes of moderate or severe vestibular symptoms lasting five minutes to 72 hours
- A current or previous history of migraine with or without aura, according to the International Classification of Headache Disorders
- One or more migraine features accompanying at least 50% of vestibular episodes: headache with at least two of the following characteristics (unilateral, pulsating, moderate to severe, aggravated by physical activity), photophobia and phonophobia, or visual aura
- Not better accounted for by another vestibular or headache disorder
A category of probable vestibular migraine exists for people who meet some but not all criteria, and this clinical category is also relevant in practice.
Why Vestibular Migraine Is So Often Missed
Several features make this diagnosis easy to overlook. Headache may be absent during vestibular episodes, leading clinicians to pursue inner ear diagnoses without considering migraine. The episodic nature and normal investigations between attacks can lead to reassurance without diagnosis. The overlap with Ménière’s disease, BPPV and PPPD adds further complexity, and all of these conditions can coexist.
A 2024 review described vestibular migraine as an underdiagnosed condition with a high prevalence across general, headache and neuro-otology clinics. The most direct route to diagnosis is a specialist assessment that combines a structured vestibular history with a migraine history and targeted vestibular examination.
Vestibular Migraine Treatment in the UK
Treatment for vestibular migraine falls into two broad approaches: acute management during episodes and preventive treatment to reduce their frequency and severity. It is important to be honest about the evidence base here. The overall quality of evidence for vestibular migraine-specific treatments is currently low, with no large, high-quality randomised controlled trials. Most current treatment is adapted from migraine management guidelines, guided by clinical experience.
Acute Treatment
During an episode, the aim is to reduce vestibular symptoms and associated nausea. Options used in practice include antiemetics, antihistamines, benzodiazepines for acute severe episodes and, where headache is also present, triptans and non-steroidal anti-inflammatory drugs.
The evidence for triptans specifically in vestibular migraine is still uncertain, though clinical use reflects their established role in migraine more broadly. Vestibular suppressants are appropriate for short-term acute use but should not be used regularly, as prolonged use can impair the brain’s ability to adapt between episodes.
Preventive Treatment
Where episodes are frequent, prolonged or significantly disruptive, preventive treatment is considered. Options borrowed from migraine prevention include beta-blockers (propranolol, metoprolol), calcium channel blockers (flunarizine), antidepressants (amitriptyline, nortriptyline, venlafaxine), antiepileptic agents (topiramate, sodium valproate) and antihypertensives such as candesartan.
A meta-analysis covering 13 medications found that all treatment options analysed resulted in some improvements, but the heterogeneity of studies and lack of standardised outcome measures mean that no clear preferred treatment strategy has yet been established.
CGRP-Targeting Therapies
One of the more significant recent developments is the exploration of anti-CGRP monoclonal antibodies in vestibular migraine. These medications, which have transformed preventive migraine treatment since 2018, are now being assessed in vestibular migraine specifically.
A retrospective review found that 15 of 25 patients showed moderate to significant improvement in vestibular symptoms with CGRP-targeting medications. The evidence remains preliminary and largely observational, but given the plausible role of CGRP in vestibular symptoms, this is an area of genuine clinical interest.
In the UK, CGRP therapies are currently funded for chronic migraine after failure of other preventive treatments. Access for vestibular migraine specifically depends on clinical presentation and local commissioning.
Vestibular Rehabilitation and Lifestyle
Vestibular rehabilitation plays a supporting role in managing vestibular migraine, particularly for people with persistent interictal symptoms or motion sensitivity. The evidence base is limited, but rehabilitation can help reduce vestibular hypersensitivity and improve functional tolerance of movement and complex visual environments.
Lifestyle measures consistent with general migraine management are recommended: regular sleep, adequate hydration, stress management, trigger identification and avoidance where practical. These are not substitutes for medical treatment in those with frequent or severe attacks, but they form an important foundation.
Frequently Asked Questions
Can you have vestibular migraine without headache?
Yes, and this is one of the most important things to understand about the condition. Headache may be mild, absent during attacks, or arrive after the vestibular episode has already settled. The absence of headache during a vestibular episode does not rule out vestibular migraine. The diagnostic criteria require only that a migraine history exists and that migraine features accompany at least half of vestibular episodes; those features do not have to include headache every time.
How is vestibular migraine different from Ménière's disease?
Both can produce episodic vertigo lasting from minutes to hours. The key differences are that Ménière’s disease typically involves fluctuating hearing loss, tinnitus and aural fullness alongside the vertigo, whilst vestibular migraine usually spares hearing. Ménière’s disease tends to produce a progression of hearing impairment over time. A migraine history is a strong pointer towards vestibular migraine. The two conditions can, however, coexist, and distinguishing them requires careful specialist assessment.
Is motion sickness related to vestibular migraine?
Yes. Motion sickness is significantly more common in people with vestibular migraine than in the general population. It often predates the onset of vertigo episodes by years and is now considered a useful diagnostic clue. Asking patients about lifelong motion sensitivity in cars, boats, or other moving environments is a practical part of the vestibular migraine history.
Will vestibular migraine go away on its own?
Some people experience a natural reduction in episodes over time, particularly in women following the menopause. However, without treatment, many people continue to have recurrent attacks that affect their daily lives. Vestibular migraine is a manageable condition. With the right preventive approach and lifestyle adjustment, frequency and severity of episodes can often be substantially reduced.
Can vestibular migraine lead to other conditions?
Yes. Vestibular migraine is one of the recognised triggers for PPPD, where the brain’s response to recurring vestibular disruption becomes chronically dysregulated. BPPV can also occur alongside or following vestibular migraine episodes. People with vestibular migraine who develop persistent daily dizziness between attacks should be assessed for both conditions.
When should I see a specialist for vestibular migraine?
Specialist assessment is appropriate when episodes are recurrent, significantly disruptive, undiagnosed after standard investigation, or when there is uncertainty about whether the cause is vestibular migraine, Ménière’s disease, BPPV or another condition. At Harley Street Audiovestibular Clinic, our audiovestibular physicians specialise exclusively in hearing and balance disorders, including the full spectrum of vestibular conditions. We take a thorough vestibular and migraine history, carry out advanced diagnostic testing where needed and provide a clear diagnosis with a structured management plan, rather than leaving you with recurring episodes and no answers.
